Controversy Around Suicidality Monitoring At Clinical Trials In Optimising Clinical Development In CNS, London, 15-16 March 2011

The absence of suicidality monitoring in previous clinical trials has lead to a number of controversies beyond those surrounding Prozac. There has been continued discussion of a link between antiepileptic drugs, psychiatric adverse effects and suicidal behaviour. In 2008 questions arose as to the existence of a link between the asthma and allergy drugs Singulair, Accolate, Zyflo, or Zyflo CR; behaviour/mood changes; and suicidality…




Health News from Medical News Today

Responses are currently closed, but you can trackback from your own site.

Comments are closed.

Copyright 2010 DiabetesSigns.org, Inc. All rights reserved. The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments. See the Terms of Service for more information. Privacy Policy

Powered by Yahoo! Answers